Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Wearable exoskeleton-assisted walking for people with recent spinal cord injury in Spanish hospitals

Official title: Robotic-SNS: A Multicenter, Randomized Trial on the Clinical and Socioeconomic Impact of Wearable Exoskeletons for Spinal Cord Injury Rehabilitation in the Spanish Healthcare System

Run by ABLE Human Motion S.L. · NCT07036107 · Data updated 2026-11-12

This trial will test whether a wearable powered lower-limb exoskeleton helps people with recent spinal cord injury walk better and lowers caregiver and healthcare costs compared with conventional therapy in Spain.

More Spinal Cord Injury trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment80 (estimated)
SponsorABLE Human Motion S.L.
Industry-sponsored
Locations2 sites (Toledo, Castille-La Mancha and 1 other locations)
StatusRecruiting
StartedJanuary 15, 2026
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedJanuary 27, 2026
Trial IDNCT07036107 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 with traumatic or non‑traumatic spinal cord injury in the acute/subacute phase (<6 months), meeting device size/weight and strength requirements (upper-limb strength to use a walker, ROM and spasticity limits) and the protocol's neurological level/AIS criteria.

Probably not a fit

People who are outside the device height/weight limits, have severe cognitive or neurological impairments preventing participation, have very high baseline walking ability (WISCI ≥ 15), or chronic injuries beyond the allowed timeframe are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with acute or subacute spinal cord injury will be randomly assigned to 24 sessions of gait rehabilitation using the ABLE wearable exoskeleton or to conventional gait therapy. The open, parallel-group design includes baseline, mid-training (after 12 sessions), end-training (after 24 sessions), and a two-month follow-up visit. Outcomes include clinical gait and function measures plus socioeconomic endpoints such as direct healthcare costs, intervention-related costs, and caregiver burden. Participants are recruited at Vall d'Hebron University Hospital (Barcelona) and the National Hospital for Paraplegics (Toledo) within the Spanish National Health System.

Why it matters

Potential benefit: If successful, the exoskeleton could improve walking outcomes while reducing caregiver strain and healthcare costs for people with recent spinal cord injury.

How similar studies have gone: Prior research with powered exoskeletons has shown promising improvements in gait and mobility but head-to-head socioeconomic comparisons versus conventional therapy remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* diagnosis of spinal cord injury (SCI) in the acute or subacute phase (\< 6 months of evolution)
* traumatic or non-traumatic aetiology
* neurological level of the SCI between C5 and L5 for patients with American Spinal Injury Association Impairment Scale (AIS) C or D, and SCI between C7 and L5 for patients with AIS A or B.
* sufficient strength in the upper extremities to handle a walker (triceps muscle score ≥ 4 according to the Medical Research Council (MRC) scale).
* range of motion (ROM) without limitations in the lower extremities (achieve at least a knee extension of 10 degrees and neutral ankle position)
* muscle spasticity in the lower extremities with a score ≤ 3 on the Modified Ashworth Scale (MAS)
* tolerate bipedalism (having stood up in the last year)
* aged between 18 and 70 years, with height between 150 cm and 190 cm, and weight less than 100 kg

Exclusion Criteria:

* WISCI ≥ 15
* cognitive or neurological limitations that prevent following instructions
* another neurologic disorder permanently affecting gait and gait therapy (other than SCI)
* grade I or higher in the European Pressure Ulcer Advisory Panel (EPUAP) in the areas of contact with the exoskeleton
* unresolved fractures at the time of the study
* uncontrolled autonomic dysautonomia
* intolerance to exercise
* uncontrolled epilepsy
* previous experience with Robotic-Assisted Gait Training (RAGT).
* ROM restriction such as flexing or arthrodesis will be excluded
* spinal instability (or spinal orthotics unless cleared by a medical doctor).
* deterioration \>3 points of the total in the motor score of the International Standards for the Neurological Classification of Spinal Cord Injury (ISNCSCI) in the last 4 weeks. Loss of sensation and/or motor activity above the level of injury detected that has not been evaluated by a doctor.

Where it's running

  • Hospital Universitario de Vall d'Hebron
    Barcelona, Catalonia, Spain
    Recruiting
  • Hospital Nacional de Parapléjicos
    Toledo, Castille-La Mancha, Spain
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.